Patents Assigned to BioSante Pharmaceuticals, Inc.
  • Patent number: 6355271
    Abstract: Novel calcium phosphate core particles, methods of making them, and methods of using them as vaccine adjuvants, as cores, as carriers of biologically active material, and as controlled release matrices for biologically active material are disclosed. The core particles may have a surface modifying agent and/or biologically active material, such as antigenic material or natural immunoenhancing factor, polynucleotide material, or therapeutic proteins or peptides, partially coating the particle or impregnated therein. The core particles have a diameter between about 300 nm and about 4000 nm, more particularly between about 300 nm and about 2000 nm, and even more particularly between about 300 nm and about 1000 nm, are substantially spherical in shape, and have a substantially smooth surface.
    Type: Grant
    Filed: February 3, 2000
    Date of Patent: March 12, 2002
    Assignee: Biosante Pharmaceuticals, Inc.
    Inventors: Steve J. D. Bell, Tulin Morco, Qing He
  • Patent number: 6183803
    Abstract: The present invention relates to methods for separating casein from milk, and for separating from milk proteins that can be associated or entrained within casein micelles, by contacting the milk with a chelating agent to disrupt the casein micelles and reconstituting the micelles by introducing small insoluble inorganic particles.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: February 6, 2001
    Assignee: BioSante Pharmaceuticals, Inc.
    Inventors: Tulin Morcol, Steve J. D. Bell